...
首页> 外文期刊>Analytical Sciences >Extraction of Volatile Anticancer Drugs in Air Using a Solid-Phase Extraction Type Device Followed by Gas Chromatography–Mass Spectrometric Analysis
【24h】

Extraction of Volatile Anticancer Drugs in Air Using a Solid-Phase Extraction Type Device Followed by Gas Chromatography–Mass Spectrometric Analysis

机译:使用固相萃取型装置提取空气中的挥发性抗癌药物,然后进行气相色谱 - 质谱分析

获取原文
           

摘要

Ifosfamide (IF), cyclophosphamide (CP), and bendamustine (BD) are widely used anticancer drugs. These drugs have slight volatility; therefore, medical-staff exposure is of concern in the medical field. However, an accurate and quantitative detection method of these volatile drugs in air has not been reported. In this study, we developed the quantitative extraction and detection method of these volatile anticancer drugs in air. For the extraction of analytes, a solid-phase extraction-type collection device packed with styrene-divinylbenzene polymer particles was used. The extracted analytes were quantitatively eluted with 5 mL of ethanol, and the solution was concentrated to 100 μL with nitrogen purging. The analytes were analyzed using gas chromatography–mass spectrometry (GC-MS). The limit of detection of the proposed method for IF and CP was 0.017 and 0.033 ng L~(?1), respectively in air at an air sampling volume of 300 L. IF and CP showed slight volatility, whereas BD was not detected in GC-MS due to its lower volatility. The spiked recoveries of IF and CP in the proposed method were within the range of 95.5 to 101%. Finally, the proposed method was applied to determine the exposure of IF and CP during the dispensing of CP within a hospital dispensary room. The investigated volatile anticancer drugs were not detected in real air samples, indicating that the protection measures employed are sufficient.
机译:Ifosfamide(IF),环膦酰胺(CP)和弯曲蛋白(BD)是广泛使用的抗癌药物。这些药物有轻微的挥发性;因此,医疗人员曝光在医学领域是令人担忧的。然而,尚未报告空气中这些挥发性药物的准确和定量检测方法。在这项研究中,我们开发了空气中这些挥发性抗癌药物的定量提取和检测方法。对于分析物的提取,使用与苯乙烯 - 二乙烯基苯聚合物颗粒包装的固相萃取型收集装置。用5ml乙醇定量洗脱萃取的分析物,用氮气吹扫将溶液浓缩至100μL。使用气相色谱 - 质谱(GC-MS)分析分析物。如果和Cp的预设方法的检测限为0.017和0.033ng L〜(Δ1),分别在空气采样体积为300L的空气中。如果和CP显示出轻微的挥发性,而BD未在GC中检测到 - 由于其较低的波动性。在所提出的方法中的IF和CP的尖刺回收率在95.5至101%的范围内。最后,应用了该方法以确定在医院药房的CP分配过程中的IF和CP的暴露。在真正的空气样本中未检测到研究的挥发性抗癌药物,表明所采用的保护措施足够。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号